An interventional study of Volume controlled ventilation and Pressure controlled ventilation in Cardiopulmonary Resuscitation, sponsored by Technical University of Munich. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-02-06.
Sponsored by Technical University of Munich · Not applicable, Interventional, and Treatment
Comparison of three ventilation modes (volume controlled, BIPAP and CPAP) during cardiopulmonary re-suscitation with a mechanical compression device in the emergency room. Primary aim is to assess mean ventilation volume in the first 15 minutes after randomization.
Mechanical compression devices are applied to grant continuous chest compressions and consequently blood flow during CPR (cardiopulmonary rescuscitation). Current guidelines, however, are lacking guidance of the optimal ventilation strategy in such scenarios. This may lead to lung injuries caused by high pressure levels in the chest while applying compression and ventilation simultaneously or hypoventilation. Consequently, this pilot study assesses iwhich ventilation mode is optimal. Patients will be assigned randomly to one of the three ventilation modes (Volume controlled, BiPAP-ASB, CPAP). Ventilation parameters will be continuously monitored for 15 minutes while blood gas analyses are taken as well. Further secondary outcome parameters will be assessed, e.g. hospital mortality.
Exclusion Criteria:
Intervention1: Ventilation with Volume controlled ventilation
Procedure: Volume controlled ventilation
Intervention2: Ventilation with Pressure controlled ventilation
Procedure: Pressure controlled ventilation
Intervention3: Ventilation with Continuous Positive Airway Pressure mode only
Procedure: CPAP mode
Volume controlled ventilation mode
Pressure controlled ventilation
CPAP mode only
mean tidal volume
mean tidal volume during the study period
Time frame: Study period = 15 min (Startpoint = Activating randomized ventilation mode Endpoint = 15 minutes after Starting point or end of CPR)
mean minute volume
mean minute volume during the study period
Time frame: Study period = 15 min (Startpoint = Activating randomized ventilation mode Endpoint = 15 minutes after Starting point or end of CPR)
etCO2
Mean, final value and course of the parameter during the study period
Time frame: Study period = 15 min (Startpoint = Activating randomized ventilation mode Endpoint = 15 minutes after Starting point or end of CPR)
paO2
Mean, final value and course of the parameter during the study period
Time frame: Study period = 15 min (Startpoint = Activating randomized ventilation mode Endpoint = 15 minutes after Starting point or end of CPR)
paCO2
Mean, final value and course of the parameter during the study period
Time frame: Study period = 15 min (Startpoint = Activating randomized ventilation mode Endpoint = 15 minutes after Starting point or end of CPR)
Ventilation setting change
We will assess changes made in the ventilator settings (mode, tidal volume, frequency, FiO2 and PEEP) during the study period
Time frame: Study period = 15 min (Startpoint = Activating randomized ventilation mode Endpoint = 15 minutes after Starting point or end of CPR)
Ventilation setting change lateron
We will assess changes made in the ventilator settings (mode, tidal volume, frequency, FiO2 and PEEP) after study period until the end of CPR
Time frame: Starting after the end of Study Period (15 min after randomized ventilation mode was activated) till cardiopulmonary resuscitation is stopped by the treating team
Ventilation hours
Ventilation hours in the hospital
Time frame: Starting point = Activation of randomized ventilation mode till End point = time when patient is discharged from the hospital; ; approximately 3 weeks
24h Survival
Survival 24h after randomization
Time frame: 24h after randomization
Hospital Survival/Mortality
Hospital Survival/Mortality
Time frame: Starting point = Activation of randomized ventilation mode till End point = time when patient is discharged from the hospital; approximately 3 weeks
BGA
Blood gas analysis
Time frame: Study period = 15 min (Startpoint = Activating randomized ventilation mode Endpoint = 15 minutes after Starting point or end of CPR)
Plan to share: No — We are willing to share anonymized and aggregated data for meta analysis or on an individual decision to collaboration partners.
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Technical University of Munich